MedTrace Logo

Virtual Gout Clinic

NCT02790463 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1463

Last updated 2019-11-12

Study results available
· View outcomes & findings →

Summary

The overarching goal of the investigators project is to identify best practices in gout and hyperuricemia management, translate these evidence-based practices into a highly generalizable strategy for optimal delivery of gout care, and implement and evaluate such a strategy in a large, population-based healthcare setting. With the use of novel but readily-accessible technology, the investigators will examine the use of a novel, large-scale, and relatively low-cost pharmacy-based intervention, with the goal of optimizing urate lower therapy (ULT) in chronic gout treatment.

Conditions

Interventions

BEHAVIORAL

Pharmacist-Led Intervention

Pharmacists will conduct outreach primarily via an automated telephone interactive voice recognition system and direct (telephone) contact

Sponsors & Collaborators

  • University of Nebraska

    collaborator OTHER

  • Kaiser Permanente

    collaborator OTHER

  • University of Alabama at Birmingham

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2018-09-30
Completion
2018-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02790463 on ClinicalTrials.gov